Streetbeat News

Stock Prices

PLX

Protalix BioTherapeutics is set to present data from its Phase I clinical trial of PRX-115, a recombinant PEGylated uricase product candidate. This development is significant for the company as it progresses in its clinical trials.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:19 am

CPRI

QQQ

SAVE

SPY

TSLA

US stocks are set to rise as Treasury yields ease. Tesla and Spirit Airlines are in focus, with Tesla seeing a significant rally and Spirit Airlines announcing aircraft sales and job cuts. Despite Tesla's strong performance, a fund manager advises caution. Capri Holdings faces a setback with its blocked acquisition by Tapestry.

Portfolio Pulse from Rounak Jain

October 25, 2024 | 11:15 am

LKFN

Lakeland Financial reported Q3 earnings of $0.91 per share, beating estimates but showing a decrease from last year. Sales were slightly below expectations but increased from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:10 am

NWL

Newell Brands shares increased following the release of their Q3 financial results and an upward revision of their 2024 guidance.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:10 am

NYCB

New York Community (NYSE:NYCB) reported Q3 2024 earnings per share of $(0.69), missing the $(0.40) estimate by 72.5%. Sales were $510M, slightly below the $512.805M estimate, marking a 42.18% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:05 am

NWL

Newell Brands has revised its FY24 normalized EPS guidance upwards to $0.63-$0.66 from the previous $0.60-$0.65 range.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:03 am

STEL

Stellar Bancorp reported Q3 2024 earnings per share of $0.63, surpassing the analyst estimate of $0.49. The company's sales were $107.809 million, also beating the estimate of $106.313 million, despite a year-over-year decrease in sales.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:03 am

AN

AutoNation's Q3 2024 earnings and sales missed analyst estimates, with EPS at $4.02 versus the expected $4.38, and sales at $6.59 billion versus the expected $6.71 billion. Both figures also show a decline compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:00 am

CL

Colgate-Palmolive shares rise due to better-than-expected Q3 earnings and updated 2024 guidance.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 10:59 am

SPY

TSLA

USO

U.S. markets closed mixed with gains in Nasdaq and S&P 500 driven by Tesla's surge. Treasury yields eased, but sentiment was cautious due to mixed corporate results. U.S. jobless claims fell, and PMI data showed improvement. Asian markets were mixed, while European markets saw slight gains. Oil prices increased, while gold and silver declined.

Portfolio Pulse from Akanksha Bakshi

October 25, 2024 | 10:47 am